Hodgkin’s lymphoma associated with hemophagocytic lymphohistiocytosis: A challenging combination

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is a hyper inflammatory disorder. In this case report, we described our experience with an associated diagnosis of Hodgkin's lymphoma (HL) and a therapeutic course using "bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone" (BEACOPP) chemotherapy to treat both HLH and HL.